Melanoma survivor T.J. Sharpe shares why patients should know their treatment options.

Genome editing advances drug discovery in biomedical research.

Accelerating Research to Get Answers Faster

Novartis opens up a path of research to protect proteins that guard against cancer.

NIBR investigator develops technology that uses tumor DNA in the blood for diagnostics

Learn how NIBR uses next generation sequencing to transform clinical trials and diagnostics in oncology.

Functional genomics study reveals a potential approach for tackling glioblastoma, pancreatic cancer and other tumors.

Read how NIBR and Dana-Farber scientists aim to expand immunotherapy options for patients

Inspired by her mother, Vicky Qi leads drug discovery teams.